. 2022 Oct;77(10):1036-1040.

doi: 10.1136/thoraxjnl-2021-218634. Epub 2022 Jul 21.

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening

Jennifer L Dickson¹, Helen Hall¹, Carolyn Horst¹, Sophie Tisi¹, Priyam Verghese¹, Anne-Marie Mullin², Jonathan Teague², Laura Farrelly², Vicky Bowyer³, Kylie Gyertson³, Fanta Bojang³, Claire Levermore³, Tania Anastasiadis⁴, Karen Sennett⁵, John McCabe¹, Anand Devaraj^{6

7}, Arjun Nair³, Neal Navani^{1

3}, Matthew Ej Callister⁸, Allan Hackshaw²; SUMMIT Consortium; Samantha L Quaife⁹, Sam M Janes^{10

3}

Collaborators, Affiliations

Collaborators

SUMMIT Consortium:
Sam M Janes, Jennifer L Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, Priyam Verghese, Andrew Creamer, Thomas Callender, Ruth Prendecki, Amyn Bhamani, Mamta Ruparel, Allan Hackshaw, Laura Farrelly, Jon Teague, Anne-Marie Mullin, Kitty Chan, Rachael Sarpong, Malavika Suresh, Samantha L Quaife, Arjun Nair, Anand Devaraj, Kylie Gyertson, Vicky Bowyer, Ethaar El-Emir, Judy Airebamen, Alice Cotton, Kaylene Phua, Elodie Murali, Simranjit Mehta, Janine Zylstra, Karen Parry-Billings, Columbus Ife, April Neville, Paul Robinson, Laura Green, Zahra Hanif, Helen Kiconco, Ricardo McEwen, Dominique Arancon, Nicholas Beech, Derya Ovayolu, Christine Hosein, Sylvia Patricia Enes, Qin April Neville, Jane Rowlands, Aashna Samson, Urja Patel, Fahmida Hoque, Hina Pervez, Sofia Nnorom, Moksud Miah, Julian McKee, Mark Clark, Jeannie Eng, Fanta Bojang, Claire Levermore, Anant Patel, Sara Lock, Rajesh Banka, Angshu Bhowmik, Ugo Ekeowa, Zaheer Mangera, William M Ricketts, Neal Navani, Terry O'Shaughnessy, Charlotte Cash, Magali Taylor, Samanjit Hare, Tunku Aziz, Stephen Ellis, Anthony Edey, Graham Robinson, Alberto Villanueva, Hasti Robbie, Elena Stefan, Charlie Sayer, Nick Screaton, Navinah Nundlall, Lyndsey Gallagher, Andrew Crossingham, Thea Buchan, Tanita Limani, Kate Gowers, Kate Davies, John McCabe, Joseph Jacob, Karen Sennett, Tania Anastasiadis, Andrew Perugia, James Rusius

Affiliations

¹ Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
² Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
³ University College London Hospitals NHS Foundation Trust, London, UK.
⁴ Tower Hamlets Clinical Commissioning Group, London, UK.
⁵ Killick Street Health Centre, London, UK.
⁶ Department of Radiology, Royal Brompton Hospital, London, UK.
⁷ National Heart and Lung Institute, Imperial College London, London, UK.
⁸ Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds, Yorkshire, UK.
⁹ Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
¹⁰ Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK s.janes@ucl.ac.uk.

PMID: 35863766
PMCID: PMC9510431
DOI: 10.1136/thoraxjnl-2021-218634

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening

Jennifer L Dickson et al. Thorax. 2022 Oct.

. 2022 Oct;77(10):1036-1040.

doi: 10.1136/thoraxjnl-2021-218634. Epub 2022 Jul 21.

Authors

Collaborators

SUMMIT Consortium:
Sam M Janes, Jennifer L Dickson, Carolyn Horst, Sophie Tisi, Helen Hall, Priyam Verghese, Andrew Creamer, Thomas Callender, Ruth Prendecki, Amyn Bhamani, Mamta Ruparel, Allan Hackshaw, Laura Farrelly, Jon Teague, Anne-Marie Mullin, Kitty Chan, Rachael Sarpong, Malavika Suresh, Samantha L Quaife, Arjun Nair, Anand Devaraj, Kylie Gyertson, Vicky Bowyer, Ethaar El-Emir, Judy Airebamen, Alice Cotton, Kaylene Phua, Elodie Murali, Simranjit Mehta, Janine Zylstra, Karen Parry-Billings, Columbus Ife, April Neville, Paul Robinson, Laura Green, Zahra Hanif, Helen Kiconco, Ricardo McEwen, Dominique Arancon, Nicholas Beech, Derya Ovayolu, Christine Hosein, Sylvia Patricia Enes, Qin April Neville, Jane Rowlands, Aashna Samson, Urja Patel, Fahmida Hoque, Hina Pervez, Sofia Nnorom, Moksud Miah, Julian McKee, Mark Clark, Jeannie Eng, Fanta Bojang, Claire Levermore, Anant Patel, Sara Lock, Rajesh Banka, Angshu Bhowmik, Ugo Ekeowa, Zaheer Mangera, William M Ricketts, Neal Navani, Terry O'Shaughnessy, Charlotte Cash, Magali Taylor, Samanjit Hare, Tunku Aziz, Stephen Ellis, Anthony Edey, Graham Robinson, Alberto Villanueva, Hasti Robbie, Elena Stefan, Charlie Sayer, Nick Screaton, Navinah Nundlall, Lyndsey Gallagher, Andrew Crossingham, Thea Buchan, Tanita Limani, Kate Gowers, Kate Davies, John McCabe, Joseph Jacob, Karen Sennett, Tania Anastasiadis, Andrew Perugia, James Rusius

Affiliations

¹ Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
² Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
³ University College London Hospitals NHS Foundation Trust, London, UK.
⁴ Tower Hamlets Clinical Commissioning Group, London, UK.
⁵ Killick Street Health Centre, London, UK.
⁶ Department of Radiology, Royal Brompton Hospital, London, UK.
⁷ National Heart and Lung Institute, Imperial College London, London, UK.
⁸ Department of Respiratory Medicine, Leeds Teaching Hospitals, Leeds, Yorkshire, UK.
⁹ Centre for Prevention, Detection and Diagnosis, Wolfson Institute of Population Health, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
¹⁰ Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK s.janes@ucl.ac.uk.

PMID: 35863766
PMCID: PMC9510431
DOI: 10.1136/thoraxjnl-2021-218634

Abstract

Eligibility for lung cancer screening (LCS) requires assessment of lung cancer risk, based on smoking history alongside demographic and medical factors. Reliance on individual face-to-face eligibility assessment risks inefficiency and costliness. The SUMMIT Study introduced a telephone-based lung cancer risk assessment to guide invitation to face-to-face LCS eligibility assessment, which significantly increased the proportion of face-to-face attendees eligible for LCS. However, levels of agreement between phone screener and in-person responses were lower in younger individuals and minority ethnic groups. Telephone-based risk assessment is an efficient way to optimise selection for LCS appointments but requires further iteration to ensure an equitable approach.

Keywords: Lung Cancer.

PubMed Disclaimer

Conflict of interest statement

Competing interests: JLD, CH, ST, HH, PV, JM, AH and SMJ are investigators for the SUMMIT Study within which the present study cohort is embedded. SUMMIT is sponsored and conducted by University College London and funded by GRAIL LLC. through a research grant awarded to SMJ as principal investigator. SLQ collaborates on the SUMMIT study and has received honorarium from Elsevier for writing a book chapter. AN is a member of the advisory board for Aidence BV. AH has received an honorarium for an advisory board meeting for GRAIL, a consultation fee for Evidera Inc for a GRAIL initiated project, and previously owned shares in Illumina. SMJ has received honoraria from Astra Zeneca, BARD1 Bioscience and Jansen for being an Advisory Board Expert and travel to a US conference. SMJ received grant funding from Owlstone for a separate research study and has a family member who is an employee of Astra Zeneca. SMJ has received travel funding for a conference from Takeda and an honorarium for planning and speaking at educational meetings from Astra Zeneca. All authors perceive that these disclosures pose no academic conflict for this study and declare no other relationships or activities that could appear to have influenced the submitted work.

Figures

**Figure 1**
Comparison between version 1 (A) and version 2 (B) of the phone screener in refining the population eligible for LHC. LCS, lung cancer screening; LHC, lung health check.

See this image and copyright information in PMC

References

1. Aberle DR, Adams AM, Berg CD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395–409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
1. de Koning HJ, van der Aalst CM, de Jong PA, et al. . Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 2020;382:503–13. 10.1056/NEJMoa1911793 - DOI - PubMed
1. Field JK, Duffy SW, Baldwin DR, et al. . UK lung cancer RCT pilot screening trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax 2016;71:161–70. 10.1136/thoraxjnl-2015-207140 - DOI - PMC - PubMed
1. Crosbie PA, Balata H, Evison M, et al. . Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester. Thorax 2018;74:405–9. 10.1136/thoraxjnl-2017-211377 - DOI - PubMed
1. Bartlett EC, Kemp SV, Ridge CA, et al. . Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation. Lung Cancer 2020;148:12–19. 10.1016/j.lungcan.2020.07.027 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening

Collaborators

Affiliations

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening

Authors

Collaborators

Affiliations

Abstract

Conflict of interest statement

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical